These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25158009)

  • 1. Post-Traumatic brain injury (TBI) presenting with Guillain-Barré syndrome and elevated anti-ganglioside antibodies: a case report and review of the literature.
    Carr KR; Shah M; Garvin R; Shakir A; Jackson C
    Int J Neurosci; 2015; 125(7):486-92. PubMed ID: 25158009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
    Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
    Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant Guillain-Barré syndrome showing severe pharyngeal-cervical-brachial weakness in the recovery phase: a case report.
    Nakamura Y; Motoki M; Hirose T; Hosokawa T; Ishida S; Arawaka S
    BMC Neurol; 2019 Jun; 19(1):145. PubMed ID: 31253118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of possible triggers of Guillain-Barre syndrome.
    Yang B; Lian Y; Liu Y; Wu BY; Duan RS
    J Neuroimmunol; 2016 Apr; 293():17-21. PubMed ID: 27049556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
    Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
    Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological assessment of Guillain-Barré syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type.
    Samukawa M; Kuwahara M; Morikawa M; Ueno R; Hamada Y; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S
    J Neuroimmunol; 2016 Dec; 301():61-64. PubMed ID: 27823807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
    Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
    J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome.
    Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M
    Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is facial diplegia regarded as a variant of Guillain-Barré syndrome?
    Kim JK; Oh SY; Sohn EH; Hong YH; Jun SM; Bae JS
    J Peripher Nerv Syst; 2015 Mar; 20(1):32-6. PubMed ID: 25975218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil.
    Rivera-Correa J; de Siqueira IC; Mota S; do Rosário MS; Pereira de Jesus PA; Alcantara LCJ; Ernst JD; Rodriguez A
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007695. PubMed ID: 31527907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
    Shahrizaila N; Yuki N
    Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.